Israel’s Teva is donating the medicines for a US study into the effectiveness of a potential combination coronavirus treatment. The study will evaluate whether combining the antibiotic azithromycin and hydroxychloroquine can prevent hospitalization and mortality from COVID-19.

https://www.algemeiner.com/2020/05/15/israeli-pharma-giant-teva-donates-medicines-for-new-nih-coronavirus-treatment-study/